# FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma

> **NCT00735241** · PHASE2,PHASE3 · WITHDRAWN · sponsor: **Sirtex Medical**

## Conditions studied

- Colorectal Carcinoma
- Liver Metastases

## Interventions

- **DEVICE:** SIR-Spheres microspheres
- **DRUG:** FOLFOX6 cycles 1-3
- **DRUG:** FOLFOX6 cycles 4 onwards
- **DRUG:** Bevacizumab cycles 3 onwards

## Key facts

- **NCT ID:** NCT00735241
- **Lead sponsor:** Sirtex Medical
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2008-07
- **Primary completion:** 2009-03
- **Final completion:** 2009-03
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Withdrawn by the study sponsor.
- **Last updated:** 2015-05-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00735241

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00735241, "FOLFOX6 Plus Sir-Spheres Microspheres Plus Avastin in Patients With Nonresectable Liver Metastases From Colorectal Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00735241. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*